about
Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMXApamin as a novel template for structure-based rational design of potent peptide activators of p53Systematic Mutational Analysis of Peptide Inhibition of the p53–MDM2/MDMX InteractionsLimitations of Peptide Retro-inverso Isomerization in Molecular MimicryA Left-Handed Solution to Peptide Inhibition of the p53-MDM2 InteractionD-peptide inhibitors of the p53–MDM2 interaction for targeted molecular therapy of malignant neoplasmsIn Vivo Activation of the p53 Tumor Suppressor Pathway by an Engineered CyclotideAn Ultrahigh Affinity d -Peptide Antagonist Of MDM2Protein grafting of p53TAD onto a leucine zipper scaffold generates a potent HDM dual inhibitorDifferences in the transactivation domains of p53 family members: a computational study.Artificial disulfide-rich peptide scaffolds with precisely defined disulfide patterns and a minimized number of isomers.Antineoplastic agents. 573. isolation and structure of papilistatin from the papilionid butterfly Byasa polyeuctes termessaLybatides from Lycium barbarum Contain An Unusual Cystine-stapled Helical Peptide ScaffoldBeta-peptides with improved affinity for hDM2 and hDMX.Mini review: protein-protein interactions in transcription: a fertile ground for helix mimetics.Designer macrocyclic organo-peptide hybrids inhibit the interaction between p53 and HDM2/X by accommodating a functional α-helix.Centipede venoms as a source of drug leads.The structure-based design of Mdm2/Mdmx-p53 inhibitors gets seriousNanoparticle-conjugated animal venom-toxins and their possible therapeutic potential.Pharmaceutical implications of helix length control in helix-mediated protein-protein interactions.Constrained peptides as miniature protein structuresIn vitro determination of the efficacy of scorpion venoms as anti-cancer agents against colorectal cancer cells: a nano-liposomal delivery approach.A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.Targeted delivery of a novel palmitylated D-peptide for antiglioblastoma molecular therapy.A stapled p53 helix overcomes HDMX-mediated suppression of p53.Evaluating the potential of a loop-extended scorpion toxin-like peptide as a protein scaffold.Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment.Small Scaffolds, Big Potential: Developing Miniature Proteins as Therapeutic Agents.Role of single disulfide linkages in the folding and activity of scyllatoxin-based BH3 domain mimetics.
P2860
Q27653993-E93C1323-7CC5-4669-9B5F-206A6B4F43F5Q27657769-28A246A9-18B5-47F9-B3A9-F99CF2BCF093Q27660219-FECAA6DE-0545-4F55-8336-125EF22FA00AQ27660480-F4FD363D-7C54-49BC-B5F0-CD6ECC83B954Q27661400-66CAEAF4-7661-47F8-BB6B-693501C2F93DQ27663612-98B55706-B947-49D5-B1DE-CFD249BD1E00Q27679062-732A876B-CE5C-4184-9D67-0888B4AAD83DQ27681154-AEF130F4-2478-4B6D-81A5-60103C37E6A3Q27690164-321202A7-8DB5-4077-8989-1BE5201893A9Q33531524-5F88D3C5-1F41-45FB-9416-B21062F0D002Q33686462-AA08EC2C-8B05-47E7-9155-E8BC11DB31C2Q33710637-9A6DB96C-CC1D-498F-9984-E5153AFE0180Q33899470-0326116A-A39D-4E2F-9AF4-98E39CEDB1F0Q34080613-856ABC9D-E5F7-42B6-ADDE-267AFBAFD4DDQ34253106-53851482-AE00-4BE6-A315-FFC82975E1D6Q35781290-6F876BA9-0EE7-48B5-B697-855DF077EA33Q36128041-A2F06BE2-CB32-40CE-A24A-C940D3DC9523Q37845797-987ECDAC-93E3-453F-A80B-9E38B3156CF0Q38067091-A8D7121F-5746-49CE-9FF0-D84CD210057CQ38164842-852B3408-62B4-4A3F-BDD1-E0750194085AQ38477058-5294F6C2-6AF6-46F8-82DF-A50DB34F5F63Q38718535-729DFDCA-6AE7-435F-BBFD-25CD2C6B566AQ38830917-C8346DCC-1020-4E70-B257-F9DA2BD0219DQ39414472-FD6EFAAB-5BF6-45C2-A362-4321BF7BB8FDQ39632109-201CFC68-DB48-4C38-B3DB-AA73AE53452CQ40564680-33A9F9C9-AC3F-483E-B1B9-03C1843CDF90Q42835397-0DDA7274-C5C0-4808-8D62-2177B924126BQ47965403-90921BC6-68A4-44E4-86A5-D06040C66EA8Q48094588-6C0E5526-E67C-4E70-8ED9-969452F6267D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Turning a scorpion toxin into an antitumor miniprotein
@en
Turning a scorpion toxin into an antitumor miniprotein.
@nl
type
label
Turning a scorpion toxin into an antitumor miniprotein
@en
Turning a scorpion toxin into an antitumor miniprotein.
@nl
prefLabel
Turning a scorpion toxin into an antitumor miniprotein
@en
Turning a scorpion toxin into an antitumor miniprotein.
@nl
P2093
P2860
P356
P1476
Turning a scorpion toxin into an antitumor miniprotein
@en
P2093
Changqing Li
Davide Zella
Guozhang Zou
Juahdi Monbo
Wei-Yue Lu
Weirong Yuan
P2860
P304
13546-13548
P356
10.1021/JA8042036
P407
P577
2008-09-18T00:00:00Z